Merck & co., inc. (MRK)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash Flows from Operating Activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

10,134

9,777

9,192

9,242

8,314

6,193

3,377

1,368

1,603

2,418

2,869

5,109

4,367

3,941

5,510

5,152

4,631

4,459

10,804

9,816

11,161

11,934

5,422

5,730

4,632

4,517

4,651

5,263

6,148

6,299

6,893

6,854

7,088

6,392

4,349

2,997

1,723

982

8,004

11,087

11,896

13,022

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and Amortization

3,575

3,652

3,714

3,963

4,280

4,519

4,688

4,748

4,620

4,676

4,694

4,715

5,103

5,471

5,846

6,241

6,299

6,375

6,388

6,429

6,574

6,691

7,072

7,166

7,068

6,988

6,695

6,713

6,862

6,978

7,178

7,358

7,386

7,427

7,432

7,409

7,525

7,381

6,764

5,278

3,819

2,576

0

0

0

Intangible asset impairment charges

936

1,040

1,160

548

400

296

270

515

566

646

3,752

3,512

3,751

3,948

654

656

425

162

93

635

1,236

1,222

1,380

831

735

765

618

658

221

200

420

402

412

705

2,686

2,853

2,716

2,441

0

0

0

-

-

-

-

Charge for future payments related to collaboration license options

-

-

-

-

-

650

400

1,150

1,150

500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity income from affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

205

226

187

278

257

294

372

395

404

583

638

665

642

666

670

582

610

524

600

587

587

790

1,242

1,787

2,235

0

0

0

Dividends and distributions from equity method affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

65

67

122

185

191

294

298

237

288

237

230

291

211

217

217

216

246

263

312

324

509

945

1,344

1,724

0

0

0

Deferred income taxes

-668

-556

-504

-400

-285

-509

-2,411

-2,607

-2,597

-2,621

-2,057

-1,673

-1,505

-1,521

17

-501

-655

-764

-1,673

-1,737

-2,475

-2,600

-1,571

-1,257

-563

-330

420

715

639

669

-846

-1,061

-1,364

-1,537

-1,323

-1,614

-1,458

-1,092

-831

852

1,819

1,821

0

0

0

Share-based Payment Arrangement, Noncash Expense

432

417

393

382

361

348

341

326

318

312

307

308

306

300

303

301

304

299

290

290

285

278

275

268

265

276

288

308

326

335

339

338

352

369

396

435

470

509

533

491

433

415

0

0

0

Other

-207

-184

-709

-727

-1,048

-978

-709

-492

-268

-190

18

-110

-103

-213

-259

-351

-405

-874

-1,295

-915

-700

-34

474

305

182

-259

-349

-257

-283

-28

-496

-922

-616

-323

57

489

-316

-377

839

356

605

535

0

0

0

Net changes in assets and liabilities:
Net changes in assets and liabilities

763

32

2,109

2,778

2,136

674

-2,138

24

25

1,087

2,020

-338

1,423

-237

2,220

1,433

262

5

1,835

-10

13

98

-2,007

-1,254

-1,033

-563

-644

953

902

1,203

1,939

836

669

262

1,606

1,640

165

160

-6,075

-3,015

2,373

-103

0

0

0

Net Cash Provided by Operating Activities

12,811

13,440

12,238

10,805

11,103

10,922

11,349

7,385

7,320

6,451

6,064

10,206

8,489

10,376

10,990

11,330

12,427

12,538

7,257

8,294

7,912

7,989

12,050

11,651

11,674

11,654

10,437

9,627

10,209

10,022

11,446

12,884

12,816

12,383

12,689

10,704

11,177

10,822

9,525

6,621

4,045

3,392

0

0

0

Cash Flows from Investing Activities
Capital expenditures

3,864

3,473

3,265

2,959

2,760

2,615

2,401

2,189

1,999

1,888

1,724

1,692

1,674

1,614

1,556

1,463

1,359

1,283

1,280

1,284

1,315

1,317

1,256

1,291

1,402

1,548

1,897

1,956

1,974

1,954

1,779

1,796

1,730

1,723

1,780

1,687

1,659

1,678

1,575

1,540

1,568

1,461

0

0

0

Purchases of securities and other investments

2,277

3,202

3,475

4,556

7,642

7,994

9,241

9,707

9,136

10,739

13,964

15,576

16,213

15,651

14,340

14,415

14,009

16,681

21,138

21,185

23,158

24,944

21,145

21,553

20,806

17,991

19,027

17,658

14,126

12,841

9,530

8,260

8,668

7,325

6,057

6,028

5,646

7,197

6,145

4,651

3,959

3,071

0

0

0

Proceeds from sales of securities and other investments

8,539

8,622

11,468

12,784

15,303

15,252

14,374

13,704

10,693

15,664

15,586

16,328

16,552

14,353

15,182

15,173

18,746

20,413

19,838

19,640

18,769

15,114

18,282

17,205

15,769

16,298

11,999

10,804

8,147

7,783

7,016

7,433

7,422

6,149

5,575

5,751

5,812

4,561

4,322

6,803

8,095

10,942

0

0

0

Acquisition of Peloton Therapeutics, Inc., net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of ArQule, Inc., net of cash acquired

2,839

294

0

0

0

-

-

-

-

396

349

970

939

780

814

303

293

146

291

181

181

181

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

256

152

141

131

130

0

0

0

Dispositions of businesses, net of cash divested

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,169

1,094

604

579

46

0

0

0

-

-

-

-

323

0

0

0

-

-

-

-

-

-

-

-

Decrease in restricted assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,257

-5,548

0

0

0

Other

-476

-378

-572

-461

-409

-102

233

298

179

-38

-625

-523

-516

-482

-99

-282

-187

-221

-114

72

190

80

199

204

46

57

-163

-246

-226

-168

-113

-19

22

30

73

-97

-120

-150

-310

-191

-185

-171

0

0

0

Net Cash (Used in) Provided by Investing Activities

-4,625

-2,629

312

1,781

4,879

4,314

2,078

1,089

-711

2,679

174

-1,387

-1,758

-3,210

-1,264

-435

3,588

-4,758

3,063

-598

-3,172

-374

-6,401

-4,716

-5,802

-3,148

-8,723

-8,525

-7,688

-6,805

-4,091

-2,515

-3,265

-2,890

-2,213

-1,756

-244

-3,497

-15,354

-3,536

-1,382

3,156

0

0

0

Cash Flows from Financing Activities
Net change in short-term borrowings

4,008

-3,710

-1,062

-477

990

5,124

306

2,067

-3,811

-26

1,053

-15

3,784

0

895

-20

-3,717

-1,540

-5,063

-103

-1,432

-460

2,767

-3,747

2,110

-159

1,055

689

870

624

-560

1,317

1,907

1,076

-127

-172

-2,727

90

554

-978

-313

-2,422

0

0

0

Payments on debt

1,951

0

1,280

1,279

3,284

4,287

3,809

3,810

1,806

1,103

301

336

1,835

2,386

2,387

2,352

855

2,906

9,515

9,517

9,516

6,617

1,267

1,265

1,272

1,775

533

535

526

22

0

0

0

-

-

-

-

1,341

689

643

639

25

0

0

0

Proceeds from issuance of debt

0

4,958

4,958

4,958

4,958

0

0

0

0

-

-

-

-

-

-

-

-

7,938

11,083

11,085

11,087

3,146

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of treasury stock

4,971

4,780

9,663

9,254

9,615

9,091

4,860

4,023

3,561

4,014

3,328

4,014

3,540

3,434

3,599

4,035

4,084

4,186

4,625

6,014

7,551

7,703

6,279

3,824

7,103

6,516

7,472

7,711

2,715

2,591

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid to stockholders

5,818

5,695

5,567

5,458

5,301

5,172

5,178

5,176

5,172

5,167

5,155

5,146

5,139

5,124

5,116

5,114

5,116

5,117

5,113

5,123

5,160

5,170

5,171

5,148

5,141

5,157

5,177

5,195

5,143

5,116

5,001

4,899

4,795

4,691

4,701

4,707

4,720

4,734

4,363

3,986

3,600

3,215

0

0

0

Proceeds from exercise of stock options

214

361

474

596

534

591

479

390

416

499

630

966

1,050

939

841

489

445

485

613

803

871

1,560

1,782

1,703

2,049

1,210

1,059

1,350

1,023

1,310

1,187

760

663

321

244

288

205

363

491

420

380

186

0

0

0

Other

-219

5

-276

-255

-334

-325

-317

-386

-255

-195

-176

-103

-116

-118

-107

-143

-78

-61

-56

11

71

79

193

112

61

60

79

86

86

86

-15

32

-186

-22

24

-48

119

-106

-131

6

-95

-126

0

0

0

Net Cash Used in Financing Activities

-8,737

-8,861

-12,416

-11,169

-12,052

-13,160

-13,379

-10,938

-14,189

-10,006

-6,198

-7,569

-4,717

-9,044

-9,473

-11,177

-13,408

-5,387

-12,753

-8,935

-11,707

-15,242

-8,094

-12,288

-2,949

-5,990

-4,584

-2,407

-3,963

-3,267

-4,280

-5,786

-6,457

-6,904

-5,968

-5,349

-7,555

-5,441

-5,995

-6,742

-304

-1,638

0

0

0

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

-66

17

-91

-69

-339

-205

-121

-10

358

457

-46

-72

-22

-131

106

-32

-871

-1,310

-1,389

-1,582

-881

-553

-275

6

-119

-346

-400

-357

-190

-30

32

-173

-133

42

-129

77

81

-295

-118

-133

-140

33

0

0

0

Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash

-617

1,967

43

1,348

3,591

1,871

-73

-2,474

-7,222

-419

-6

1,178

1,992

-2,009

359

-314

1,736

1,083

-3,822

-2,821

-7,848

-8,180

-2,720

-5,347

2,804

2,170

-3,270

-1,662

-1,632

-80

3,107

4,410

2,961

2,631

4,379

3,676

3,459

1,589

-11,942

-3,791

2,219

4,943

0

0

0